By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche said today that it has partnered with Cellular Dyanmics and Acea Biosciences on technologies for the early and accurate prediction of cardiotoxic side effects in the drug discovery process.

The alliance will combine Cellular Dynamics' induced pluripotent stem cell-derived heart cells, called iCell Cardiomyocytes, with Roche's xCelligence RTCA System, a label-free cell analysis system which was co-developed by Acea.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

In Science this week: environmental DNA can help in studies of marine animals, and more.